Autoimmune hepatitis type 2

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:563581K75.4
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Autoimmune hepatitis type 2 (AIH-2) is a rare liver disease where the body's immune system mistakenly attacks healthy liver cells. Unlike most autoimmune liver diseases that mainly affect adults, AIH-2 most often affects children and teenagers, though adults can also develop it. It is sometimes called anti-LKM1 positive autoimmune hepatitis, named after a specific antibody found in the blood of most people with this condition. In AIH-2, the immune system produces antibodies — mainly anti-liver kidney microsomal type 1 (anti-LKM1) antibodies — that target a protein called CYP2D6 found in liver cells. This ongoing immune attack causes inflammation and, over time, can lead to scarring of the liver (cirrhosis) if left untreated. Symptoms can include yellowing of the skin and eyes (jaundice), extreme tiredness, belly pain, and a swollen abdomen. The good news is that AIH-2 responds well to treatment in most cases. Doctors typically use corticosteroids like prednisone and immune-suppressing drugs like azathioprine to calm the immune system and protect the liver. With proper treatment, many patients can live full lives, though lifelong medication and regular monitoring are usually needed. In severe cases, a liver transplant may be considered.

Also known as:

Key symptoms:

Extreme tiredness and low energyYellowing of the skin and whites of the eyes (jaundice)Pain or discomfort in the upper right bellySwollen belly due to fluid buildup (ascites)Nausea and loss of appetiteDark-colored urinePale or clay-colored stoolsItchy skinJoint painEnlarged liver or spleenUnexplained weight lossEasy bruising or bleedingSkin rashes

Inheritance

Multifactorial

Caused by a mix of several genes and environmental factors

Age of Onset

Variable

Can begin at different ages, from infancy through adulthood

Orphanet ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Autoimmune hepatitis type 2.

View clinical trials →

No actively recruiting trials found for Autoimmune hepatitis type 2 at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Autoimmune hepatitis type 2 community →

No specialists are currently listed for Autoimmune hepatitis type 2.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Autoimmune hepatitis type 2.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Autoimmune hepatitis type 2Forum →

No community posts yet. Be the first to share your experience with Autoimmune hepatitis type 2.

Start the conversation →

Latest news about Autoimmune hepatitis type 2

No recent news articles for Autoimmune hepatitis type 2.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Questions for your doctor

Bring these to your next appointment

  • Q1.How severe is my liver disease right now, and is there already any scarring?,What is the treatment plan, and how long will I need to take these medications?,What side effects should I watch for with prednisone and azathioprine?,How will we know if the treatment is working, and what does remission look like?,What are the signs of a relapse, and what should I do if I notice them?,Are there any dietary changes or supplements I should make to protect my liver?,At what point would a liver transplant be considered, and what does that process involve?

Common questions about Autoimmune hepatitis type 2

What is Autoimmune hepatitis type 2?

Autoimmune hepatitis type 2 (AIH-2) is a rare liver disease where the body's immune system mistakenly attacks healthy liver cells. Unlike most autoimmune liver diseases that mainly affect adults, AIH-2 most often affects children and teenagers, though adults can also develop it. It is sometimes called anti-LKM1 positive autoimmune hepatitis, named after a specific antibody found in the blood of most people with this condition. In AIH-2, the immune system produces antibodies — mainly anti-liver kidney microsomal type 1 (anti-LKM1) antibodies — that target a protein called CYP2D6 found in liver

How is Autoimmune hepatitis type 2 inherited?

Autoimmune hepatitis type 2 follows a multifactorial inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.